Clinical Trial: Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: A Randomized, Double-blind, Placebo-controlled Ascending Dose Study to Evaluate the Effect of APL180 on Endothelial Function in Patients With Familial Hypercholesterolemia
Brief Summary: This study will evaluate the effect of APL180 on endothelial function measured by forearm venous occlusion plethysmography in patients with familial hypercholesterolemia.
Detailed Summary:
Sponsor: Novartis Pharmaceuticals
Current Primary Outcome: Change in forearm blood flow during each treatment
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Novartis
Dates:
Date Received: September 11, 2008
Date Started: September 2006
Date Completion:
Last Updated: September 22, 2016
Last Verified: September 2016